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Abstract
Objectives. The osteochondral junction can be a source of pain in both RA and OA. Growth of blood
vessels and nerves from the subchondral bone into articular cartilage may mediate the association
between joint pathology and symptoms. We have investigated associations between angiogenesis,
inflammation and neurovascular growth factor expression at the osteochondral junction in human arthritis.
Methods. Osteochondral junctions from medial tibial plateaux of patients undergoing arthroplasty for RA
(n=10) or OA (n=11), or from non-arthritic post-mortem controls (n=11) were characterized by immuno-
histochemistry for CD34 and smooth muscle a-actin (blood vessels), CD68 (macrophages), CD3 (lympho-
cytes), proliferating cell nuclear antigen, vascular endothelial, platelet-derived and nerve growth factor
(NGF).
Results. Osteochondral angiogenesis was demonstrated as increased endothelial cell proliferation and
vascular density in non-calcified articular cartilage, both in RA and OA. Osteochondral angiogenesis
was associated with subchondral bone marrow replacement by fibrovascular tissue expressing VEGF,
and with increased NGF expression within vascular channels. RA was characterized by greater lympho-
cyte infiltration and PDGF expression than OA, whereas chondrocyte expression of VEGF was a particular
feature of OA. NGF was observed in vascular channels that contained calcitonin gene-related peptide-
immunoreactive sensory nerve fibres.
Conclusions. Osteochondral angiogenesis in RA and OA is associated with growth factor expression by
cells within subchondral spaces, vascular channels and by chondrocytes. NGF expression and sensory
nerve growth may link osteochondral angiogenesis to pain in arthritis.
Key words: Rheumatoid arthritis, Osteoarthritis, Subchondral bone, Inflammation, Pathological neovasculariza-
tion, Nerve growth, Calcitonin gene-related peptide, Knee, Immunohistochemistry.
Introduction
Subchondral pathology may importantly contribute to
both RA and OA. Subchondral inflammatory infiltrates
in RA contain lymphocytes, produce chemokines and
MMPs [1, 2], and are osteoclastic [2–4]. In OA, subchon-
dral bone plate thickening may stress and damage the
overlying cartilage [5], and may impair nutrition to its
deeper layers [6]. OA and RA both result in chondropathy,
and RA leads eventually to secondary OA, identifiable by
the development of marginal osteophytes (OSTs) [7]. In
both OA and RA, subchondral bone may be a source of
pain [8–10].
Loss of integrity of the osteochondral junction is descri-
bed in both RA and OA, attributed in RA to ‘subchondral
erosions’ [1, 11, 12] and in OA described as ‘vascular
channels’, both indicating subchondral bone remodelling
[5, 8, 13–15]. Blood vessels are localized to channels that
breach the osteochondral junction, but are rarely found
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17]. Fine, unmyelinated sensory nerves accompany blood
vessels within vascular channels and may contribute to
pain in OA [8, 10]. The factors that lead to the vascular-
ization and innervation of the articular cartilage in human
arthritis are little understood.
Synovitis is not only characteristic of RA, but also a key
feature of OA [18]. Subchondral inflammation is well
described in RA [1, 2], and may also be a feature of OA,
where fibrovascular tissue replaces fatty bone marrow
[19]. These expansile, proliferating lesions may extend to
communicate with the articular surface, and may be asso-
ciated with bone marrow lesions observed by MRI [20],
and with subchondral cytokine and MMP expression [21].
Synovial angiogenesis is associated with, and appar-
ently dependent on, inflammation, both in RA and OA
[16, 18, 22]. However, osteochondral angiogenesis was
associated with chondropathy rather than synovitis in
OA [16, 23], indicating that osteochondral and synovial
angiogenesis are concurrent but differentially regulated
processes. Subchondral inflammation and neovasculari-
zation have been noted to co-exist in RA [1, 2], but a
possible contribution of subchondral inflammation to
osteochondral angiogenesis has received little attention.
VEGF and PDGF are important mediators of blood
vessel growth. VEGF stimulates endothelial cell (EC)
proliferation and migration, and stabilizes newly formed
blood vessels, whereas PDGF recruits pericytes and
smooth muscle cells, leading to vascular maturation [24].
Sensory nerve growth is stimulated by nerve growth factor
(NGF), which is also up-regulated in inflamed synovium
[25]. NGF can also stimulate angiogenesis, demonstrating
the often close link between blood vessel and nerve
growth [26]. It is unknown, however, whether these
same factors are available to stimulate osteochondral,
as well as synovial angiogenesis and nerve growth.
We hypothesized that osteochondral angiogenenesis
and sensory nerve growth are driven by growth factors
produced by cells within the subchondral bone spaces
and vascular channels. By comparing tibiofemoral
samples from patients with RA or OA with those from
post-mortem (PM) controls, we characterized the sub-
chondral cellular milieu and investigated possible associ-
ations with vascular growth.
Methods
Patient samples
Patients fulfilled the ARA criteria for RA (n=10, two males)
or OA (n=11, eight males). PM controls (n=11, five males)
had macroscopically normal tibial plateaux and no visible
OSTs. Additional samples from three patients (PM; n=2,
OA; n=1, all males) were processed to permit evalu-
ation of the relative distributions of NGF- and calcitonin
gene-related peptide (CGRP) immunoreactivities. Written
consent was obtained from all patients or, for PM cases,
next of kin [27], according to the Declaration of Helsinki.
The study was approved by the UK National Research
Ethics Service or its predecessors (reference numbers
NNHA/420, NNHA/544, NNHA/673 and 05/Q2403/24,
05/Q2403/61 and 08/H0403/13). Postero-anterior knee
radiographs were allocated scores for joint space narrow-
ing (JSN) and osteophytosis using a standardized line
atlas [28].
Formalin-fixed coronal sections of the middle third of
medial tibial plateaux were decalcified in 10% EDTA
in 10mM Tris buffer (pH 6.95, room temperature) and
then were wax embedded. Decalcification was confirmed
by radiography. Samples used for co-localization of
CGRP-immunoreactive nerves with NGF were fixed by
the method of Zamboni [29], using a solution of 2%
(w/v) paraformaldehyde, 15% (v/v) picric acid in phos-
phate buffer (pH 7.3) overnight at 4 C, and then trans-
ferred to 15% (w/v) sucrose in phosphate buffered
saline (PBS/sucrose) solution at 4 C for 5 days.
Zamboni’s fixed tissues were decalcified as above,
except at 4 C, then immersed and frozen in optimal cut-
ting temperature and stored at  80 C.
Histomorphometry
Sections were cut with a thickness of 5mm, or, for CGRP-
and NGF-co-localization, 20mm. Immunoreactivities
were detected without (VEGF, NGF, CGRP and a-actin)
or after (CD3, CD68 and PDGF-B) antigen retrieval,
respectively, in 10mM Tris/1mM EDTA (pH 9.0, 95 C for
20min), or 1mg/ml pepsin in 0.5M acetic acid (37 C for
2h) or 10mM citrate buffer (pH 6, 95 C for 20min).
Proliferating ECs were visualized following antigen
retrieval in 10mM citrate buffer (pH 6, 90 C for 5min),
using double-sequential immunohistochemistry for prolif-
erating cell nuclear antigen (PCNA; clone PC10) and CD34
[22]. Visualization used avidin–biotin complex (ABC)-
peroxidase or -alkaline phosphatase and diaminobenzi-
dine (DAB) alone or with nickel enhancement [30] or
FastRed
TM.
All histomorphometry were performed blinded to diag-
nostic group, by methods appropriate to the distribution
of staining, based on initial qualitative analyses. Samples
without articular cartilage were excluded from analysis.
Vascular density/millimetre tidemark was determined as
channels (20–120mm wide) terminating in the subchondral
bone, calcified cartilage and non-calcified cartilage.
Subchondral bone plate thickness was subchondral
bone plate sectional area [measured using a KS300
computer-assisted image analysis system (Imaging
Associates, Bicester, UK)], divided by tidemark length
(measured by digital caliper; Mitutoyo, Andover, UK). Sub-
chondral bone plate area included spaces occupied by
vascular channels and excluded subchondral bone
spaces. OA severity (chondropathy) score was modified
from Mankin, excluding tidemark integrity (possible range
0–13) [8, 14, 16].
CD3-immunoreactive cells were graded in subchondral
bone as: 0, none; 1, 51 cell not dispersed widely; and
2, positive cells widely dispersed. VEGF-immunoreactive
cells were graded in subchondral bone as: 0, none;
1, 410%; and 2, >10% of cells; and in vascular channels
as occupying: 0, <20%; 1, 20–70%; and 2, >70% of
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channels as occupying: 0, none; 1, <50%; and 2, 550%
of channels. CD68-positive mononuclear cells were
graded in the subchondral bone as: 0, none; 1, focal/
sparse distribution; and 2, high density; and in vascular
channels as occupying: 0, none; 1, <1%; 2, 1–5%; and
3, >5% of channel section area. NGF expression was
measured as proportion of vascular channels displaying
positive cells.
Statistical analysis
Data were analysed with Statistical Package for Social
Sciences, version 14 (SPSS Inc., Chicago, IL, USA),
using Kruskal–Wallis test with post hoc Mann–Whitney
U-test, Spearman’s rank correlation coefficients or  
2
statistic. P<0.05 after correction for multiple compari-
sons indicated statistical significance. Data are median
and interquartile range (IQR).
Materials
Mouse mABs to CD34 (QBEnd10), CD3 (F7.2.38) and
CD68 (PG-M1) were from DakoCytomation (Cambridge,
UK), and to a-actin (1A4) from Sigma Chemical Co.
(Poole, UK). Rabbit polyclonal anti-PDGF (H55),
anti-VEGF (A20) and anti-NGF (H-20) were from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Rabbit
polyclonal anti-CGRP (T-4239) was from Peninsula
Laboratories (Belmont, CA, USA). Biotinylated secondary
antibodies, Vectastain ABC-peroxidase Elite and
ABC-alkaline phosphatase were from Vector
Laboratories Ltd (Peterborough, UK). Mayer’s haematoxy-
lin and eosin were obtained from Raymond A. Lamb Ltd
(East Sussex, UK). Ammonium chloride, DePeX mounting
medium, Superfrost Plus microscope slides, PBS (pH 7.5)
and CaCl2 were from VWR International Ltd (Lutterworth,
UK). Orthophosphate buffered formalin was from Cell
Path PLC (Wales, UK). All other chemicals and reagents
were from Sigma Chemical Co (Poole, UK).
Results
Patient details
Radiographic severity (Table 1) and disease duration were
similar in RA and OA, with 8 (RA) and 10 (OA) patients
reporting disease for >5years. All RA cases displayed
tibiofemoral OSTs on radiographs. Effusion was detected
in the index knee of six patients with RA and five with OA.
Disease-modifying anti-rheumatic agents were used by
eight patients with RA (seven MTX, three ciclosporin and
one SSZ), oral corticosteroids by five patients (four RA
and one PM), bisphosphonates by two and oestrogens
by a further one patient with RA.
General morphology
Morphology of the tibial plateaux (Table 1 and Fig. 1) was
as previously reported [16]. Articular cartilage displayed
varying degrees of chondropathy. The subchondral bone
plate was of variable thickness and subchondral bone
spaces were occupied by soft tissue of two predominant
types: fatty tissue containing bone marrow or fibrovascu-
lar tissue containing matrix, mononuclear and vascular
cells (Fig. 1A). Chondropathy, subchondral bone thick-
ness and fibrovascular marrow replacement each dis-
played heterogeneity between disease groups ( 
2=8.2,
P=0.017;  
2=7.7, P=0.021; and  
2=10.5, P=0.005, re-
spectively). RA cases displayed greater chondropathy,
thinner subchondral bone plates and more frequent fibro-
vascular marrow replacement than PM, with intermediate
values in OA (Table 1).
Osteochondral vascularity
CD34-positive cells and smooth muscle a-actin-positive
cells were each organized in luminated vessel-like struc-
tures, often containing erythrocytes, consistent with EC
and pericyte/vascular smooth muscle cell morphology
(Fig. 1B and C). Blood vessels were observed within
both marrow and fibrovascular types of subchondral
tissue and in vascular channels. Vascular channels were
observed in all disease groups as extensions of the sub-
chondral bone spaces. PCNA-positive ECs were
observed in vessels within subchondral bone spaces
and in vascular channels, often alongside PCNA-positive
non-vascular cells (Fig. 1C).
Numbers of vascular channels terminating in the
non-calcified articular cartilage or in the subchondral
bone displayed heterogeneity between disease groups
( 
2=10.2, P=0.006 and  
2=9. 1, P=0.01, respectively).
Vascular densities for OA and RA cases were higher in
the non-calcified cartilage, and lower in the subchondral
bone than for PM cases (Table 1). Presence of proliferat-
ing ECs within vascular channels that breached the
tidemark displayed heterogeneity between disease
groups ( 
2=6.7, P=0.04; Fig. 1C and Table 1). RA
cases were more likely to display proliferating ECs in vas-
cular channels than were PM cases (Z= 2.0, P=0.02).
Cases that displayed PCNA-positive ECs within vascular
channels displayed higher vascular densities within
the non-calcified cartilage [0.85 (0.57–1.1) per mm] than
did those without evidence of EC proliferation [0.16 (0.11–
0.34) per mm, Z=3.2, P=0.001].
High vascular density in the non-calcified cartilage was
associated with greater chondropathy and fibrovascular
marrow replacement (Table 2). EC proliferation within vas-
cular channels was also associated with greater chondro-
pathy (Z=2.4, P=0.04).
Inflammatory cells
CD3-positive lymphocytes were localized within subchon-
dral bone spaces in each disease group and occasionally
within vascular channels. Only cases with RA displayed
CD3-positive cells in those vascular channels that invaded
the articular cartilage (Fig. 2A). CD3-positive cells in sub-
chondral bone spaces displayed heterogeneity between
disease groups ( 
2=15.4, P=0.004), being increased in
both RA and OA, and most abundant in RA (Table 1).
CD68-positive mononuclear cells in subchondral bone
spaces and vascular channels displayed the appearance
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with similar frequency and density in all three disease
groups (Table 1). Some CD68-positive multinucleated,
osteoclast-like cells were observed. CD68-positive cells
in vascular channels were more abundant in cases that
displayed proliferating ECs in vascular channels (Z=2.1,
P=0.04), but no other significant associations were de-
tected between subchondral inflammatory cell infiltration
and angiogenesis indices (Table 2).
Growth factors
VEGF-, PDGF- or NGF-positive cells were localized to
blood vessels and non-vascular cells within vascular
channels and subchondral bone spaces (Figs 3 and 4).
PDGF- or NGF-positive cells were often adjacent to the
bone surface. Vascular channels containing CGRP-
immunoreactive nerve fibres also contained NGF-
positive cells (Fig. 4E and F). VEGF, PDGF and NGF
were also localized to chondrocytes. VEGF-positive
chondrocytes were predominantly localized to the super-
ficial zone of articular cartilage of OA cases (Fig. 3C) and
NGF-positive chondrocytes were localized to superficial
but not deep articular cartilage in all disease groups
(Fig. 4D).
VEGF-positive superficial chondrocytes and PDGF-
or NGF-positive cells in vascular channels each dis-
played heterogeneity between disease groups ( 
2=8.20,
P=0.02;  
2=12.9, P=0.002;  
2=9.2, P=0.01, respect-
ively). VEGF-positive chondrocytes were most common
in OA; PDGF-positive cells in vascular channels were
most abundant in RA; and vascular channels more com-
monly contained NGF-positive cells in OA and RA, than in
PM (Table 1). VEGF and NGF expressions within vascular
channels and VEGF expression by superficial chondro-
cytes were each associated with higher vascular densities
in the non-calcified cartilage (Table 2).
TABLE 1 Clinical and pathological characteristics compared between RA, OA and PM controls
Clinical or pathological characteristic RA OA PM
Age, years 68 (60–74) 61 (55–68) 50 (42–69)
Gender, female, % 80 27 55
Serum CRP, mg/l 18 (11–26)
z <5( <5–6) NA
Radiography
JSN (0–6) 4.8 (5–6) 5 (4.8–5.325) NA
OSTs (0–12) 10 (8–12) 9 (8–10.3) NA
General morphology
Chondropathy (0–13) 8.5 (5.5–10.3)* 8 (4–10) 4 (3–5)
Subchondral bone thickness, mm 0.12 (0.11–0.17)* 0.17 (0.16–0.21) 0.18 (0.14–0.25)
Subchondral fibrovascular tissue (Y/N), % 90** 55 18
Vascularity
Vascular density, per mm
Non-calcified cartilage 0.45 (0.18–0.83)* 0.42 (0.15–0.82)* 0.09 (0.07–0.19)
Calcified cartilage 0.80 (0.57–0.97) 0.71 (0.68–0.86) 1.2 (0.88–1.8)
Subchondral bone 2.1 (0.6–2.6)** 2.5 (1.6–4.0)* 5.3 (2.7–8.1)
EC proliferation
Vascular channels, % 55*3 6 0
Subchondral spaces, % 55 45 11
Inflammatory cells
CD3 subchondral spaces (0–2) 2 (0.8–2)**
,y 0.5 (0–1)* 0 (0–0.8)
CD68 subchondral spaces (0–2) 1.5 (0.8–2) 1 (1–2) 1.5 (1–2)
Growth factor expression
VEGF
Subchondral spaces (0–2) 1 (0–2) 0 (0–1) 1 (0–2)
Channels (0–2) 0.5 (0–1) 0.5 (0–1) 1 (0–1)
Chondrocytes, % 27 82*1 8
PDGF
Subchondral spaces (0–2) 1 (0–1) 0 (0–1) 0 (0–0)
Channels (0–2) 2 (1–2)**
,y 1 (0–1) 0 (0–1)
NGF
Subchondral spaces, % 38 63 33
Channels (proportion positive) 0.50 (0.08–0.69)* 0.54 (0.05–0.79)* 0.14 (0.00–0.43)
Chondrocytes, % 100 75 78
Histological parameters are presented in subchondral bone spaces, vascular channels and (for VEGF and NGF), superficial
chondrocytes. Values given as per cent indicate percentage of cases displaying that characteristic. Statistically significant
differences between disease groups are highlighted in bold: RA or OA vs PM *P<0.05, **P<0.01; RA vs OA yP<0.05,
zP<0.01. Values are median (IQR) for measurements and scores, or percentage of cases displaying the named characteristic.
NA: not available.
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Osteochondral angiogenesis was increased in RA and OA
compared with non-arthritic knees, associated with both
chondropathy and subchondral pathology. Our findings
support the hypothesis that osteochondral angiogenesis
is mediated by a pro-angiogenic environment within
subchondral bone marrow spaces, enhanced in OA
by angiogenic stimuli from articular chondrocytes. Osteo-
chondral angiogenesis was also associated with
increased NGF expression, and may facilitate the sensi-
tization or growth into articular cartilage of sensory nerves.
Our observational data from human tissues provide a
basis for the validation of models of OA, which could be
used to test the clinical implications and molecular mech-
anisms underlying associations between blood vessel and
nerve growth.
Osteochondral angiogenesis
Vascularization of articular cartilage variously has been
attributed to normal ageing [17, 31], loading [17] or OA
and RA pathological change [8, 14, 16, 23, 32].
Standardized tissue collection from medial tibial plateaux
FIG.1Morphology and vascularity at the osteochondral junction in RA, PM controls and OA. (A) General morphology
at the osteochondral junction. RA: fibrovascular granulation tissue filling bone marrow spaces and invading the
articular cartilage from below. There is proteoglycan loss and thinning of the articular cartilage and subchondral bone
plate. Inset: blood vessel and inflammatory cells within the subchondral bone space. PM: normal cartilage, thick sub-
chondral bone containing vascular channels and bone marrow spaces filled with fatty tissue. OA: fibrovascular tissue
within a channel touching the tidemark (inset) as well as fibrillation, fissuring and proteoglycan depletion in cartilage at the
articular surface. (B) Smooth muscle a-actin-positive cells (black) in subchondral bone spaces and associated vascular
channels. Insets: positive blood vessels within a vascular channel (RA) and subchondral space (OA). (C) Vascular
channels stained for CD34-positive ECs (red), PCNA-positive nuclei (black) and non-proliferating nuclei
[40-60-diamidino-2-phenylindole (DAPI): fluorescent blue]. Proliferating ECs (long arrows) are demonstrated in a vascular
channel that crosses the tidemark (broken line) in RA, and within the subchondral bone plate in OA. Proliferating non-ECs
are also present (RA: short arrows). PM: vascular channel within the subchondral bone plate containing no proliferative
ECs. Tissue morphology is revealed in (A) by Safranin O stain (red: proteoglycan; green: bone), with haematoxylin
counterstain or (B and C) using combined transmitted and fluorescent light (blue/white: cartilage, bone and DAPI-reactive
nuclei; yellow: background). Scale bars=100 microns.
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the osteochondral junction
Non-calcified cartilage vascular density per millimetre
Z-value R-value Parameter present Parameter absent
General morphology
Cartilage score – – – 0.40*
Subchondral bone thickness – – –  0.38
Subchondral fibrovascular tissue 0.34 (0.19–0.68) 0.15 (0.07–0.21)  2.5** –
Inflammatory cells
CD68 subchondral spaces – – –  0.18
CD3 subchondral spaces – – – 0.34
Growth factor expression
VEGF
Subchondral spaces – – – 0.38
Channels – – – 0.45*
Chondrocytes 0.57 (0.18–0.89) 0.16 (0.09–0.34)  2.0* –
PDGF
Subchondral spaces 0.61 (0.17–0.83) 0.21 (0.14–0.62)  1.1 –
Channels – – – 0.28
NGF
Subchondral spaces 0.25 (0.15–0.47)  0.19 (0.02–0.55)  0.7 –
Channels – – 0.52**
Chondrocytes 0.20 (0.14–0.54) 0.08 (0.00–0.28)  1.7 –
Vascular densities are given as median (IQR) for cases displaying (present) or not displaying (absent) dichotomous parameters,
followed by Z-score for comparison by Mann–Whitney U-test. Associations between vascular density and continuous or
ordinal parameters are given as Spearman’s rank correlation coefficients. Histological parameters are presented in subchon-
dral bone spaces, vascular channels and (for VEGF and NGF) superficial chondrocytes. Significant associations are highlighted
in bold. *P<0.05, **P<0.01.
FIG.2Inflammatory cells in subchondral bone spaces and associated vascular channels. (A) CD3-positive lymphocytes
(black) within fibrovascular tissue occupying subchondral bone spaces in RA and OA, but not in the fatty marrow of
a PM control. Inset: subchondral bone space showing CD3-positive lymphocytes (arrows). Bo: bone; CC: calcified
cartilage; NCC: non-calcified cartilage; broken line: tidemark. (B) CD68-positive cells (black) in RA, PM controls and OA.
Mononuclear CD68-positive cells resembled macrophages and were localized either at the bone surface, or deeper
within the subchondral bone space. Multinucleated CD68-positive cells localized at the bone surface (insets) resembled
osteoclasts. Tissue morphology is revealed by combined transmitted and fluorescent light (blue/white: cartilage, bone;
yellow: background). Scale bar = 100 microns.
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in the current study. Associations between osteochondral
vascularity and chondropathy are independent of ageing
in animal models [33] and earlier data demonstrating
increasing osteochondral vascularity from the seventh
decade may be attributed to increasing prevalence of
OA [31]. Our data support the hypothesis that increased
vascularity in the non-calcified cartilage is a pathological
feature of both OA and RA.
Vascular density in the non-calcified cartilage is a
measure of osteochondral angiogenesis, as shown by
its association with increased EC proliferation. Earlier
methods inferring angiogenesis based on direct contact
between channel contents and articular cartilage (open
channels) [17, 31, 34] were not specifically associated
with chondropathy [34], possibly due to confounding
by sectioning artefacts and new bone deposition.
We show that vascularity of the subchondral bone plate
is decreased in diseased compared with control joints,
probably due to a combination of thinning of the subchon-
dral bone plate (in RA), and ossified channels that no
longer contain soft tissue or evidence of vascularization
[17]. In contrast, vascular channels breaching the tide-
mark were more abundant in diseased than in normal ar-
ticular cartilage, and were associated with more severe
chondropathy [16, 23].
Subchondral pathology and osteochondral
angiogenesis
Fibrovascular replacement of adipose marrow tissue is a
feature of both RA [1, 2, 11] and OA [1, 19]. Bone marrow
lesions detected by MRI may sometimes reflect such
marrow replacement, and have been associated with
knee pain [35]. New blood vessels within the articular car-
tilage originate from subchondral bone marrow spaces,
and we found that osteochondral angiogenesis was
associated with fibrovascular marrow replacement.
This may suggest that subchondral pathology drives vas-
cular invasion into articular cartilage, or that angiogenesis
or associated factors may stimulate fibrovascular marrow
replacement. Fibrovascular marrow replacement also
FIG.3Vascular growth factor expression in articular cartilage and bone. (A) VEGF-positive cells (brown) in vascular
channels (RA, PM and OA), and in bone marrow spaces (RA). (B) PDGF-positive cells (brown). Vascular channels dis-
playing PDGF-B-positive cells within the matrix and adherent to the bone surface in RA and OA, but not PM.
(C) Chondrocytes displaying VEGF immunoreactivity in deep (RA) and superficial (OA) articular cartilage, but not in PM.
Tissue morphology is revealed by combined transmitted and fluorescent light (blue/white: cartilage, bone; yellow:
background) (A and B) or by haematoxylin counterstain (C). Scale bar = 100 microns.
PM OA RA
A
B
C
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meniscal transection model of OA in rats [33], raising the
possibility of testing the relationship between these
phenomena in interventional studies.
Subchondral marrow replacement by fibrovascular
tissue in RA previously has been compared with synovial
pannus, containing lymphocytes and invading the articular
cartilage through the subchondral bone plate [2, 11, 36].
Subchondral tissues are, however, distinct from syno-
vium. Synovial pannus in OA typically does not invade
cartilage [37], whereas subchondral vascular tissues
invade into the non-calcified cartilage in both OA and
RA. Synovial angiogenesis is associated with synovial
macrophage infiltration [16, 22], whereas osteochondral
angiogenesis was not associated with inflammatory cell
infiltration in the current study. We previously did not
find any association between osteochondral and synovial
angiogeneses or synovitis in OA [16]. Subchondral tissues
may influence osteochondral angiogenesis in ways that
are distinct from the regulation of synovial vascular
growth during synovitis.
Osteochondral angiogenesis in both RA and OA may be
facilitated through the up-regulation of angiogenic factors
within subchondral tissues. Angiogenic cytokines such as
IL-1a, IL-8 and IL-10 have been localized to subchondral
stromal cells both in RA and OA [21, 38], and we similarly
demonstrate expression of both VEGF and PDGF.
Increased expression of angiogenic factors by articular
chondrocytes may also contribute to osteochondral
angiogenesis [39]. The drive for osteochondral angiogen-
esis may differ between RA and OA, as suggested by our
findings of higher expression of PDGF in RA and VEGF
expression by superficial chondrocytes in OA.
NGF
Neovascularization of the non-calcified articular cartilage
is associated with its innervation by fine, unmyelinated
sensory nerves [8, 10]. We have demonstrated increased
NGF immunoreactivity in patients with OA or RA
compared with non-arthritic controls, colocalized with
CGRP-immunoreactive nerve fibres within vascular chan-
nels. NGF expression was associated with osteochondral
vascularity, and sensory nerve growth may be facilitated
by the expression of NGF during osteochondral angio-
genesis. Furthermore, NGF sensitizes nerves [40], such
that increased NGF expression in RA and OA may
FIG.4NGF expression in articular cartilage and bone. NGF-positive cells (brown) in vascular channels in the medial
tibial plateau of patients with OA (A) and RA (C), but not in a non-arthritic control (B). (D) Chondrocytes displaying
NGF immunoreactivity (brown) in superficial articular cartilage from a patient with OA (E and F). Co-localization within
a vascular channel of NGF immunoreactivity (E, red) and a CGRP-immunoreactive nerve (F, black, arrow), demonstrated
in serial tissue sections from a patient with OA. (A–D) DAB development with haematoxylin counterstain. (E) FastRed
development. (F) Nickel-enhanced DAB development. Filled arrow heads: tidemark. Open arrow head: articular surface.
Scale bar=100 microns.
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Increased NGF production, therefore, may contribute
to OA pain, both structurally (increased and aberrant
innervation at the osteochondral junction), and through
peripheral sensitization.
Nerve growth follows neovascularization in a variety of
tissues, including subcutaneous sponge granulomas and
healing fractures in animal models [41, 42]. Some growth
factors, including NGF, may induce both blood vessel and
nerve growth [26]. NGF produced by vascular cells may
contribute to the growth of sensory nerves along newly
formed vessels. However, the expression of NGF by
non-vascular cells within vascular channels may suggest
a more general stimulation of nerve growth, with direction
along the neovasculature perhaps determined by other, as
yet undefined, factors.
Interpretation of our findings is limited by a number of
factors. Cross-sectional observational studies such as
ours cannot prove causality. Immunohistological differ-
ences between PM and arthritic samples may have
been confounded by PM tissue changes. However,
such changes would be unlikely to influence compari-
sons between RA and OA, or structural components
such as osteochondral vascular density, fibrovascular
marrow replacement or bone plate thickness. Although
not statistically significant, the PM group had a lower
median age than either arthritic group. The high preva-
lence of OA in older populations makes age matching of
PM samples difficult, and we elected in this study, by
excluding all PM cases with macroscopic evidence of
chondropathy, to avoid disease group contamination in
preference to selecting age-matched cases. These limi-
tations may be addressed through interventional studies
in validated animal models that reflect those changes
observed in man.
Conclusions
Osteochondral angiogenesis is a complex process that
may be moderated by cells in the subchondral bone
spaces, and by chondrocytes. Our data support potential
roles for VEGF and NGF in human arthritis, and identify
angiogenesis and nerve growth at the osteochondral
junction as putative targets for therapeutic intervention.
However, observational studies on human tissues can
only support, rather than prove, hypothesized contribu-
tions of angiogenesis and nerve growth to clinical disease.
Interventional studies are needed to determine whether
neurovascular growth at the osteochondral junction may
be a useful therapeutic target.
Rheumatology key messages
. Neurovascular growth is associated with VEGF,
PDGF and NGF expression at the osteochondral
junction.
. The osteochondral angiogenic milieu differs
between RA and OA, and from that supporting
synovial vascular growth.
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